Holmium:YAG- und erbium :YAG-infrarotlaser-osteotomie

Zusammenfassung Die knochenablative Wirksamkeit der gepulsten Festkörperlaser Holmium:YAG ( = 2120 nm) and Erbium:YAG ( = 2940 nm) wurde im Tierversuch vergleichend untersucht. Als Modell für eine klinische Anwendung wurden partielle Oberkiefer-, Unterkiefer-und Nasenbeinosteotomien an der Ratte durchgeführt. In einer ersten Versuchsreihe wurden die unmittelbare klinische Wirkung und das histologische Wirkungsprofil dieser Infrarotlaser am Hartgewebe erforscht und die Temperaturgradienten im Knochen während der Laseranwendung gemessen. Die geringe Ausdehnung der Schädigungszone im Randbereich der Laserinzisionen und das für den Erbium:YAG-Laser praktisch atraumatische, athermische Knochenabtragungsvermögen läßt die neuen Infrarotlaser als ideale Schneidegeräte für Osteotomien erscheinen.

---

Holmium:YAG laser and erbium:YAG laser infrared laser osteotomy

Summary The in-vivo bone ablation characteristics of a pulsed solid-state erbium:YAG laser were compared to those of a pulsed solid-state holmium:YAG laser. Partial osteotomies in the maxillary, the mandibulary, and the nasal bones of white rats were performed. The tissue response was examined by light microscopy. Thermal gradients following the laser application were also measured. Over all energy levels tested the erbium:YAG laser produced ablation of bone with minimal thermal damage to the adjacent tissue. The results of this study are promising for future application of the infrared holmium-and erbium:YAG lasers in otorhinolaryngology.

     

Lutzomyia longipalpis (Diptera: Psychodidae: Phlebotominae): a review

Lutzomyia longipalpis is the most important vector of AmericanVisceral Leishmaniasis (AVL) due to Leishmania chagasi in the New World. Despite its importance, AVL, a disease primarily of rural areas, has increased its prevalence and became urbanized in some large cities in Brazil and other countries in Latin America. Although the disease is treatable, other control measures include elimination of infected dogs and the use of insecticides to kill the sand flies. A better understanding of vector biology could also account as one more tool for AVL control. A wide variety of papers about L. longipalpis have been published in the recent past years. This review summarizes our current information of this particular sand fly regarding its importance, biology, morphology, pheromones genetics, saliva, gut physiology and parasite interactions.     

Erbium: YAG versus holmium:YAG lithotripsy

PURPOSE: We test the hypothesis that erbium:YAG (Er:YAG) lithotripsy is more efficient than holmium:YAG (Ho:YAG) lithotripsy. MATERIALS AND METHODS: Human calculi composed of greater than 97% calcium oxalate monohydrate and cystine were studied. Calculi were irradiated in water using Er:YAG or Ho:YAG lasers. Er:YAG lithotripsy was done with a 425 microm sapphire optical fiber at a pulse energy of 50 mJ at 10 Hz. Ho:YAG lithotripsy was performed with a 365 microm low hydroxy optical fiber at a pulse energy of 500 mJ at 10 Hz or a 425 microm sapphire optical fiber at a pulse energy of 50 mJ at 10 Hz. Fragmentation was defined as the initial stone mass minus the final dominant fragment mass and normalized for incident laser fluence (energy per unit area of fiber tip). RESULTS: Mean fragmentation plus or minus standard deviation for calcium oxalate monohydrate was 38 +/- 27 mg for Er:YAG and 22 +/- 6 for Ho:YAG (low hydroxy silica fiber) versus 5 +/- 1 for Ho:YAG (sapphire fiber, p = 0.001). When fragmentation was normalized for incident laser fluence given different optical fiber sizes, mean fragmentation efficiency was 53.6 +/- 38.7 g-microm2/J for Er:YAG lithotripsy compared with 22.6 +/- 6.4 for Ho:YAG (low hydroxy silica fiber) lithotripsy (p = 0.04). Mean cystine fragmentation was 15 +/- 3 mg for Er:YAG versus 9 +/- 1 for Ho:YAG (sapphire fiber, p = 0.0005). CONCLUSIONS: Er:YAG lithotripsy is more efficient than Ho:YAG lithotripsy.     

Clinical audit: introduction: getting started

Clinical audit can benefit your practice and your patients. It is one of the pillars of clinical governance that will ensure that SAAD members deliver the best quality dental care. If you have experience of clinical audit that you would like to share with members, we would like to hear about it, so other members can learn from your experience.